Skip to main content

Logo
  • Live News iconLive News
  • Smart Screener iconSmart Screener
  • Trade Opportunities iconTrade Opportunities
  • Alpha Watch iconAlpha Watch
  • Catalyst iconCatalyst
Skip to main content
Stock Ask Logo
Hi, Guest User

Log in or create an account to get full access

Open an Account (opens in a new window)

TOOLS

Live News
Smart Screener
Trade Opportunities
Alpha Watch
Catalyst

StockkASK powered by Indira Securities

ANG Lifesciences India Ltd (ANG) Share Price & Fundamentals

SegmentOfferingsAdvantages / MoatCustomersHigh-Margin AreasRevenue (₹ Cr.)Revenue %How We EarnPricing ModelGrowth DriversTop Brands
PharmaceuticalsManufacture and sale of sterile dry powder injections, tablets, capsules, syrups, injections, and pre-filled syringes.GMP compliance, ISO certification, dedicated manufacturing facilities for Beta Lactum and Non-Beta Lactum products.B2B; hospitals, doctors, healthcare providers primarily in India.Sterile dry powder injectable formulations due to specialization and quality standards.8894Sales of pharmaceutical finished formulations to hospitals, doctors via stockists.Direct sales through distribution network; pricing aligned with market and regulatory policies.Healthcare demand growth, new product launches, improved distribution reach.
Packaging and printingPharmaceutical packaging and printing services following backward integration strategy.Ownership of packaging supplier enhances cost control and operational efficiency.B2B; pharmaceutical manufacturers including internal group use.Packaging for sterile pharmaceutical products; enables margin protection.46Sales and supply of packaging materials internally and externally.Supply contracts and sales agreements; cost optimization focus.Backward integration, cost reduction, ensuring supply chain stability.

StockkASK provides smart, AI-powered insights to support analysis. AI can make mistakes; verify independently before investing.Terms & Conditions